Traditional Chinese medicine composition for turning myopia deepening process

By using a combination of traditional Chinese medicine ingredients, including Smilax glabra, saffron, Ligusticum chuanxiong, Fritillaria cirrhosa, Pueraria lobata, Osmanthus fragrans, Gastrodia elata, Dendrobium nobile, and menthol, and extracting the effective components with ethanol, this method treats myopia and solves the problems of insignificant treatment effects and significant side effects in existing technologies. It achieves vision restoration and wide applicability.

CN121754624APending Publication Date: 2026-03-31邵昆
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2025-04-21
Publication Date
2026-03-31

Smart Images

  • Figure FT_1
    Figure FT_1
  • Figure FT_2
    Figure FT_2
Patent Text Reader

Abstract

The invention relates to a traditional Chinese medicine composition, in particular to a traditional Chinese medicine composition for treating postnatal myopia, and particularly relates to a traditional Chinese medicine composition for treating postnatal myopia. , Szechuan fritillary bulb, kudzuvine root and sweet osmanthus; the invention relates to a compound preparation composed of rhizoma gastrodiae, dendrobium and menthol. The invention aims to provide the traditional Chinese medicine composition which can obviously reduce myopia until the vision of eyes is recovered to 1.0 or above and has small side effects.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention belongs to the field of A61K 36 / 00 (traditional Chinese medicine / natural medicine), specifically relating to a traditional Chinese medicine composition for treating acquired myopia, and particularly to a compound preparation composed of Smilax glabra, saffron, Ligusticum chuanxiong; Fritillaria cirrhosa, Pueraria lobata, Osmanthus fragrans; Gastrodia elata, Dendrobium nobile, and menthol. Background Technology

[0002] Currently, there are almost no medications available for the clinical treatment of myopia; for example, low-concentration atropine sulfate eye drops (0.01%) can only slow the progression of myopia. Surgical treatment also has inherent instability, and the pool of people who can undergo the procedure is limited. Therefore, there is an urgent need for a myopia treatment product that is suitable for a wide range of people, has significant efficacy, and minimal side effects. Summary of the Invention

[0003] This invention aims to provide a method that can significantly reduce myopia, even restoring visual acuity to 1.0 (using " International Standards "Visual acuity chart / decimal record method" A traditional Chinese medicine composition with the above (and few) side effects.

[0004] Technical solution Formula composition: There are three independent combinations of proportions: Part 1: Smilax glabra (5g), saffron (0.1g), chuanxiong (5g); Part 2: Fritillaria cirrhosa (3g), Pueraria lobata (5g), Osmanthus fragrans (1.5g); Part 3: Gastrodia elata (5g), Dendrobium nobile (3g), Menthol (0.1g).

[0005] Preparation method: 1. First, the raw materials of Chinese medicinal herbs are subjected to ultra-high temperature instantaneous sterilization (UHT); 2. Next, the sterilized Chinese medicinal materials are mixed in proportions of 1, 2, and 3 and the active ingredients are extracted with ethanol.

[0006] 3. Extract with ethanol at 20℃ for 12 hours.

[0007] use: Treatment for nearsightedness. Detailed implementation method: 1. The efficacy of this traditional Chinese medicine composition was simulated using the [Traditional Chinese Medicine-Human Body Interactive Simulation System] developed by myself. In this system, the ethanol extracts of parts 1, 2, and 3 of the composition exhibit superior interactive performance. The system shows that it can reverse the progression of 200 degrees of myopia in just 7 days; and restore visual acuity to 1.0 in a 200-degree myopia patient within one month (using "…"). International Standard Vision Chart (Decimal) (Recordation of vision) .

[0008] [Traditional Chinese Medicine-Human Interaction Simulation System] Simulation results are attached. Figure 1 Appendix Figure 2 . Attached Figure Description

[0009] Appendix Figure 1 This is a diagram illustrating the eye parameters used in the simulation of the eye physiological indicators of the <Traditional Chinese Medicine-Human Body Interaction Simulation System (Eyeball)> of this invention; Appendix Figure 2 This is a schematic diagram of eye parameters used in the simulation of the negative effects on eye tissues in the <Traditional Chinese Medicine-Human Interaction Simulation System (Eyeball)>.

Claims

1. A traditional Chinese medicine composition, characterized in that, Each portion consists of the following raw materials by weight: Smilax glabra (5 grams), saffron (0.1 gram), Chuanxiong Rhizoma (5 grams); Fritillaria cirrhosa (3 grams), Pueraria lobata (5 grams), Osmanthus fragrans (1.5 grams); Gastrodia elata (5 grams), Dendrobium nobile (3 grams), menthol (0.1 gram).

2. The traditional Chinese medicine composition according to claim 1, characterized in that The composition is divided into three independent uses (Smilax glabra (5 grams), saffron (0.1 gram), Chuanxiong Rhizoma (5 grams) for portion 1; Fritillaria cirrhosa (3 grams), Pueraria lobata (5 grams), Osmanthus fragrans (1.5 grams) for portion 2; Gastrodia elata (5 grams), Dendrobium nobile (3 grams), menthol (0.1 gram) for portion 3).